DNAAF4-CCPG1

Across TCGA pan-cancer cohorts, DNAAF4-CCPG1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated DNAAF4-CCPG1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher DNAAF4-CCPG1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAAF4-CCPG1 expression acts as an unfavorable survival marker, although some lineages such as ACC and LUAD show a favorable association.

READ, MESO, and CHOL are the cancer types where DNAAF4-CCPG1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	III,IV	0.055	0.781	<.001	63	view →
MESO	DFS	Tertile	III,IV	0.238	0.419	.004	48	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
COAD	OS	Tertile	IV	0.230	0.663	.008	36	view →
ACC	DFS	Tertile	IV	0.800	0.247	.004	28	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
TGCT	DFS	Tertile	All	0.447	0.697	.032	18	view →
SKCM	DFS	Tertile	III,IV	0.222	0.565	.016	15	view →
LUAD	DFS	Quartile	IV	0.939	0.588	.033	9	view →
LIHC	OS	Tertile	All	0.291	0.713	.015	9	view →
THCA	OS	Quartile	All	0.950	0.993	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

DNAAF4-CCPG1–READ (DFS)

Open the READ breakdown →